Therefore, despite reduced Treg levels’ association with a better survival, as reported in the C1498 AML mice model [36], anti-PD-L1 use in AML management should be undertaken with caution considering other anti-cancer drugs implemented in the therapy. Here, CD274 is linked to cancer.